Showing results (1371-1380 of 1,487) with videos related to
Sort By:
Pageof 149
Journal for Immunotherapy of Cancer|April 5, 2025
MHC class II-mediated spontaneous rejection of breast carcinomas expressing model neoantigensJames William Jenkins, Alvaro Peña, Sarah A Castro, et al.Cancer Causes & Control : CCC|April 1, 2017
Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysisSean Harrison, Rosie Lennon, Jeff Holly, et al.Journal of Medicinal Chemistry|January 22, 2008
Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophyJohn Thurmond, Matthew E R Butchbach, Marty Palomo, et al.Biorxiv : the Preprint Server for Biology|June 21, 2024
Imputation of ancient canid genomes reveals inbreeding history over the past 10,000 yearsKatia Bougiouri, Sabhrina Gita Aninta, Sophy Charlton, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|February 10, 2022
Free Achilles tendon strain during selected rehabilitation, locomotor, jumping, and landing tasksDaniel Devaprakash, David F Graham, Rod S Barrett, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2023
Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung CancerKavya Ramkumar, Azusa Tanimoto, Carminia M Della Corte, et al.Cancer|August 10, 2021
Blood and Marrow Transplant Clinical Trials Network Study 1102 heralds a new era in hematopoietic cell transplantation in high-risk myelodysplastic syndromes: Challenges and opportunities in implementationErica D Warlick, Celalettin Ustun, Astrid Andreescu, et al.Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Isoindolinone ureas: a novel class of KDR kinase inhibitorsMichael L Curtin, Robin R Frey, H Robin Heyman, et al.Bioorganic & Medicinal Chemistry Letters|June 1, 2006
Isothiazolopyrimidines and isoxazolopyrimidines as novel multi-targeted inhibitors of receptor tyrosine kinasesZhiqin Ji, Asma A Ahmed, Daniel H Albert, et al.Bioorganic & Medicinal Chemistry Letters|March 26, 2008
Scaffold oriented synthesis. Part 2: Design, synthesis and biological evaluation of pyrimido-diazepines as receptor tyrosine kinase inhibitorsVijaya Gracias, Zhiqin Ji, Irini Akritopoulou-Zanze, et al.Pageof 149